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ABSTRACT
FUNCTIONAL ANALYSIS OF THE CAF1 PROTEIN
by
Takbum Ohn 
Universidty of New Hampshire, September, 2006
The CAF1 protein is a component of the CCR4-NOT deadenylase complex. 
While yeast CAF1 displays deadenylase activity, this activity is not required for its 
function in vivo, and CCR4 is the primary deadenylase in the complex. In order to 
identify CAF1-specific functional regions required for deadenylaton in vivo, we targeted 
for mutagenesis six regions of CAF1 that are specifically conserved among CAF1 
ortho logs. Defects in three regions of the CAF1 protein (residues 173-175, residues 255- 
257 and residues 340-342, alleles cafl-1 , cafl-3 and cafl-6, respectively) were found to 
dramatically reduce the rate of deadenylation in vivo and to result in typical cq/7 deletion 
phenotypes without critically affecting the ability of CAF1 to bind CCR4. In contrast, 
defects in residues 213-215, which were defined as the site required for binding CCR4 
{cafl-2 allele), reduced the rate of deadenylation to a lesser extent than did cafl-1, -3 or -  
6 and its in vivo phenotypes were correspondingly less severe than these other alleles. 
The cafl-1, -3, and -6 alleles or a cafl deletion, unlike that of ccr4 or cafl-2, were 
synthetically lethal with defects in DHH1, a decapping regulator that is involved in 
controlling translation, and with certain defects in poly(A) binding protein (PAB1) that 
display decreased rates of translation and deadenylation. A cafl deletion also had a more
viii
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significant effect on translation than did ccr4. These and other genetic experiments 
suggest a role for CAF1 in translation separate from that of CCR4. Conversely, a pabl 
translation defect that did not affect deadenylation by itself or with ccr4 severely blocked 
deadenylation when coupled with a cafl deletion. These results support a role for CAF1 
in communications between translation and deadenylation that are required for both 
processes.
ix
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GENERAL INTRODUCTION
The regulation of gene expression is a fundamental aspect of all biological 
processes. The degradation of eukaryotic mRNA plays significant roles in modulating 
gene expression since the mRNA pool in the cell is determined both by the rates of 
synthesis and of degradation. In eukaryotes, the regulated decay of mRNAs can occur 
through two general mechanisms: deadenylation-dependent and -independent decay 
pathways (Figure 1). Monitoring of mRNA fidelity can be performed through specialized 
decay mechanisms such as nonsense-mediated decay (NMD) and nonstop decay (Figure 
1).
1. Deadenylation-dependent mRNA decay pathways
1.1. Deadenylation
A principal mRNA degradation pathway used in eukaryotes is usually initiated by 
removal of the 3’ poly(A) tail. Evidence that the poly(A) tail removal is required for 
mRNA degradation comes from assessing the kinetics of deadenylation relative to the 
decay of several yeast and mammalian mRNAs (Brewer and Ross 1998; Shyu et al., 
1991; Decker and Parker, 1993). Transcriptional pulse-chase experiments showed that 
these mRNAs do not degrade completely until their poly(A) tails have been shortened. 
Moreover, mRNAs that are known to be unstable are also deadenylated more rapidly than 
a stable mRNA. The unstable MFA2 transcript, for instance, was deadenylated with a 3-
1
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fold higher rate (-13 A’s/min) than the stable PGK1 transcript (~4 A’s/min) 
(Decker and Parker, 1993). Thus, deadenylation is an initial rate limiting step in mRNA 
decay.
The understanding of the mechanisms of mRNA degradation is mainly based on 
studies in Saccharomyces cerevisiae. Deadenylation of the 3’ poly(A) tail to a length that 
is too short to bind the major poly(A)-binding protein, PAB1, leads to one of two 
different degradation pathways in yeast (Figure 2). The loss of PAB1 leads to disruption 
of the eIF4F translation initiation complex (consisting of eIF4E, eIF4G and PAB1) which 
is bound to the 5’ cap structure via the cap binding protein eIF4E. The destabilized 
mRNP structure causes decapping followed by final 5’-3’ exonucleolytic cleavage by 
XRN1 (Figure 2) (Hsu and Stevens, 1993).
1.2. Decapping
Decapping (5’ cap hydrolysis) depends on almost complete deadenylation 
(5~10A’s) and has been proved to be a highly conserved decay mechanism in eukaryotic 
cells (Dunckley and Parker, 1999; Lykke-Andersen J., 2002; Wang et al; 2002). First, the 
decapping enzymes, DCP1 and DCP2, are conserved among eukaryotes (Dunckley and 
parker, 1999; Lykke-Andersen J. 2002; Wang et al., 2002). Secondly, decapped mRNAs 
are specifically detected on mammalian transcripts with short poly(A) tails (Couttet et al., 
1997). More recently, decapping components were found to be aggregated in well- 
conserved discrete cytoplasmic foci termed P-body (Sheth and Parker, 2000; van Dijk et 
al., 2002; Lykke-Andersen, 2002). This specialized cellular structure is also known to be 
involved in translational control that is very similar to another form of mRNA containing 
cytoplasmic particles, referred to as a stress granule (Kedersha and Anderson, 2002).
2
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Decapping is catalyzed by the decapping complex which is composed of DCP1 
and DCP2. DCP1 is absolutely required for in vivo decapping process but the 
recombinant protein is inactive. Thus, DCP1 has been suggested to undergo a DCP2- 
dependent activation to become decapping competent (Dunckley et al., 2001). DCP2 is a 
member of the Nudix family of pyrophosphatases, emzymes that hydrolyse nucleoside 
diphosphates and mutations in the DCP2 Nudix motif inactivate decapping activity in 
vivo and in vitro (Dunckley and Parker, 1999; Lykke-Andersen J., 2002; Steiger et al., 
2003; Wang et al., 2002). The recombinant DCP2 protein is active in vitro and releases 
m7GDP from a capped RNA, leaving a 5’ monophosphate on the RNA. It also showed a 
capped RNA substrate preference as the rate of hydrolysis of free m7GpppN is very low. 
The activity increases significantly when the length of the RNA is increased from around 
20-50 to -100 nucleotides (Steiger et al., 2003; Stevens, 1998; van Dijk et al., 2002), 
suggesting the existence of an RNA-binding site on DCP2 that is distinct from the active 
site. These RNA binding sites were subsequently identified in the C-terminal part of the 
Nudix domain (Piccirillo et al., 2003).
Several proteins have been identified as the regulators of the decapping process. 
EDC1 and EDC2 proteins stimulate decapping in yeast and these two proteins have 
sequence similarity to each other. EDC1 associates with the DCP1/DCP2 complex 
(Dunckley et al., 2001). Mutations in the PAT1 gene reduce the rate of decapping in vivo 
but have no effect on cap hydrolysis in vitro suggesting that it is not directly involved in 
the catalytic step (Bonnerot et al., 2000; Bouveret et al., 2000; Hatfield et al., 1996). 
PAT1 is associated with the LSM complex which also promotes decapping probably by 
binding the 3’ end of the mRNA (He and Parker, 2001). Another protein associated with 
the LSM complex is DHH1, a member of the DEAD box ATPase family. The homolog of
3
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DHH1 in higher eukaryotes is the rck/p54 protein, which has been demonstrated to have 
ATP- or GTP-dependent RNA helicase function (Cougot et al., 2004; Ladomery et al., 
1997; Minshall et al., 2001). Of these decapping stimulators, PAT1 and DHH1 have also 
reported to be involved in translation (Wyers et al., 2000; Coller and Parker, 2005).
1.3. 5’ to 3’ decay
5’-3’ exonucleolytic cleavage is the final step of the major deadenylation 
dependent mRNA decay pathway. This step is conducted by XRN1, a divalent cation- 
dependent processive 5’-exonuclease. Capped RNA is resistant to XRN1 cleavage, and 
RNA carrying a 5’ monophosphate is strongly preferred over 5’ hydroxylated RNA. This 
enzyme is also evolutionarily conserved among eukaryotes (Bashkirov et al., 1997; Till 
et al., 1998; Newbury and Woollard, 2004).
1.4. 3’ to 5’ decay
Eukaryotic mRNAs can also be degraded in a 3’ to 5’ direction following 
deadenylation by the exosome, a complex of 3’-5’ exonucleases (Muhlrad et al., 1995; 
Jacobs Anderson and Parker, 1998). It is clear that the 3’ to 5’ degradation pathway is 
considerably slower in yeast than decapping and subsequent 5’ to 3’ degradation 
(Muhlrad et al., 1995; Anderson and Parker, 1998). However, either pathway by itself is 
sufficient to support cell viability (Anderson and Parker, 1998). Mutations that inhibit 
both pathways are synthetically lethal, which suggests that these are the only two general 
pathways of mRNA decay in yeast. The exosome exists both in the nucleus and in the 
cytoplasm. The nuclear and the cytoplasmic exosome from yeast share a set of ten 
subunits. Nine of these form a stable core complex except RRP44 which is loosely
4
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associated (Allmang et al., 1999; Mitchell and Tollervey, 2000). Six subunits, 
RRP41/SKI6, RRP42, RRP43, RRP45, RRP46, and MTR3, have sequence similarity to 
E. coli polynucleotide phosphorylase (PNPase) and RNase PH, suggesting that like these 
two enzymes they catalyze the 3’-5’ degradation of RNA by phosphorolytic attack, 
releasing nucleoside 5’ diphosphates (Allmang et al., 1999; Mitchell et al., 1997). Two 
additional subunits of the yeast exosome, RRP4 and RRP44, have hydrolytic 3’ 
exonuclease activities (Mitchell et al., 1997). The RRP40 subunit may also be a 
hydrolytic enzyme, based on its sequence similarity to RRP4. No catalytic activity has 
been predicted for the CSL4/SKI4 subunit. Four additional polypeptides are not stably 
associated with the exosome but contribute to exosomal mRNA degradation in the 
cytoplasm: SKI2, SKI3, SKI7, and SKI8. These proteins are not involved in nuclear 
functions of the exosome (Jacobs Anderson and Parker, 1998; van Hoof et al., 2000). 
SKI2, SKI3, and SKI8 form a complex (Brown et al., 2000) and SKI2 is a predicted 
RNA helicase.
2. Deadenylation-independent mRNA decay pathways
2.1. Nonsense-mediated decay (NMD)
mRNA decay can also be initiated by decapping and 5’-3’ decay of the transcript 
independent of poly(A) shortening. Eukaryotic cells has evolved complex mRNA 
surveillance mechanisms to increase the fidelity of gene expression by monitoring and 
degrading aberrant mRNAs that, if translated would produce truncated proteins that is 
often harmful to the cell viability. For instance, aberrant mRNAs containing a premature 
translational stop codon are decapped without prior poly(A) shortening (Cao and Parker,
5
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2003; Muhlrad and Parker, 1994). This rapid degradation of aberrant transcripts is 
referred to as nonsense-mediated decay (NMD). In yeast, NMD involves the normal 
translational machinery which, upon recognition of a premature termination codon, 
triggers decapping without prior deadenylation thereby allowing the 5’ to 3’ 
exonucleolytic cleavage by XRN1 (Muhlrad and Parker, 1994; Hagan et al., 1995; 
Beelman et al., 1996; Hatfield et al., 1996). Additional proteins that are required in NMD 
are the UPF1, UPF2 and UPF3 proteins. UPF1 has been purified from yeast and shown 
to contain RNA binding as well as RNA-dependent ATPase and RNA helicase activities 
(Czaplinski et al., 1995; Weng et al., 1996). UPF2 is an acidic protein without significant 
homology to other proteins and UPF3 is a protein that is capable of shuttling between the 
nucleus and cytoplasm (He and Jacobson, 1995). These proteins cause rapid decapping 
without deadenylation by recognizing an improper translation termination and interacting 
with the translation termination factor eRF3 (Weng et al., 1996).
2.2. Non-stop decay (NSD)
Transcripts lacking termination codons are also subjected to rapid degradation; 
however, the mechanism is quite different from NMD. Nonstop decay (NSD), unlike 
NMD, is localized to the cytoplasmic compartment in both mammalian and yeast cells. 
This process is performed by the exosome nuclease complex and begins at the 3’- 
poly(A) tail. This exosomal nuclease activity requires SKI7 which is an exosome- 
associated protein and related to the translation elongation factor EF1A and the 
translation termination factor eRF3. Therefore, the likely function of SKI7 is to 
distinguish nonstop from normal mRNAs by binding to the empty A site of stalled 
ribosomes that have reached the 3’ end of a mRNA. This interaction could bring the
6
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exosome to the mRNA as SKI7 interacts with both the ribosome and the exosome (van 
Hoof et al., 2002; Frischmeyer et al., 2002).
2.3. Endonucleolytic Cleavage
Eukaryotic mRNAs can be degraded via endonucleolytic cleavage prior to 
deadenylation. Evidence for this mechanism comes from the analysis of transcripts, such 
as c-myc, insulin-like growth factor II (IGF-I1), mammalian 9E3, serum albumin, 
transferring receptor, vitellogenin mRNA, and Xenopus /3-globin mRNA where 
fragments are detected in vivo that correspond to the 5’ and 3’ portion of the transcript 
and are consistent with internal cleavage with the mRNA (Binder et al., 1994; Bremer et 
al., 2003; Hanson and Schoenberg, 2001; Stoeckle and Hanafusa, 1989; van Dijk et al.,
2001). It is likely that a variety of endonucleases may exist with different sequence- 
specific cleavages because there does not appear to be any similarity between the 
cleavage sites in these mRNAs. For example, the endonuclease which is responsible for 
cleaving (3-globin mRNA appears to be recognize at UG and UC dinucleotides (Bremer 
et al., 2003), whereas the decay of eNOS pre-mRNA appears to occur by cleavage at CA 
repeats (Hui et al., 2003). Recently, endonucleolytic cleavage mechanism has found to be 
the major pathway of RNA induced silencing process (RNAi). RNAi response is initiated 
by the recognition o f dsRNA by the ATP-dependent endonuclease Dicer that cleaves 
dsRNA to generate 21-23 nucleotide RNA species used to target the RNAi-induced 
silencing complex (RISC) to the complementary mRNA.
7
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3. Control of mRNA deadenylation
3.1. c/.s’-acting elements
The control of mRNA degradation is often coded inside the mRNA body which 
is usually found in the 3’ untranslated region (3’-UTR). Several czs-acting elements 
stimulating the mRNA deadenylation have been identified in yeast and higher eukaryotes. 
The mRNAs for transiently expressed proteins such as transcription factors, growth 
factors, cytokines and proto-oncogenes usually contain AU-rich elements (AREs) in the 
3-UTR. These AREs are characterized by the presence of one or multiple copies of the 
pentanucleotide AUUUA and a high U content. For example, class I AREs contain one to 
three copies of AUUUA repeats embedded in U-rich sequences and are present in early 
response genes (c-fos, c-myc) and cytokine encoding genes. Class II AREs contain five to 
eight AUUUA copies and are only found in cytokine mRNAs (GM-CSF, TNF-J3 and IL- 
3). Class III AREs contain a long U-rich sequence instead of AUUUA repeats and these 
elements are found in the c-jun proto-oncogene and P-adrenergic receptor mRNAs.
cA-acting destabilizing elements have also found in the coding regions in the 
mammalian c-fos (Wellington et al., 1993; Schiavi et al., 1994), c-myc (Wisdom and Lee, 
1991), Drosophila fushi tarazu (Ito and Jacobs-Lorena, 2001) and yeast M ATal 
transcripts (Shyu et al., 1991; Caponigro and Parker, 1996)). The function of these 
elements requires movement of the ribosome across the RNA harboring them. For 
example, in the yeast M ATal transcript, the ability of a 32 nucleotide region to stimulate 
deadenylation and degradation is stimulated by a region of rare codons just 5’ to this 32 
nucleotide suggesting that the presence of paused ribosome is required for this element to 
function (Parker and Jacobson, 1990; Caponigro et al., 1993).
8
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3.2. trans-acting factors
It has been increasingly clear that factors involved in controlling mRNA 
degradation processes include a variety of mRNA binding proteins. The Pumilio- 
homology domain-protein families (PUF) of RNA-binding proteins have been shown to 
bind 3-UTR sequences and accelerate the targeted mRNA degradation (Zamore et al., 
1997). In yeast, PUF3 is the first protein that has been shown to promote deadenylation 
of COX17 transcript by binding its 3-UTR (Olivas and Parker, 2000). PUF3 does not 
affect translation but interacts directly with the mRNA degradation machinery. Hence, 
PUF-proteins, as specific regulators of mRNA deadenylation, have been conserved 
throughout eukaryotes (Olivas and Parker, 2000). Another yeast PUF protein, PUF5, 
inhibits the expression of the HO gene by promoting the decay of the HO mRNA through 
binding its 3’-UTR (Tadauchi et al., 2001). Recently, a genome-wide microarray analysis 
identified yeast PUF mRNA targets that are functionally related (Gerber et al., 2004).
4. CCR4-NOT complex, the deadenylation machinery in yeast
The evolutionarily conserved CCR4-NOT protein complex was initially thought 
to be a general transcriptional regulatory complex involving from transcription initiation 
to termination (Collar!, 2003; Denis and Chen, 2003). The components of 1.0-MDa core 
complex were identified as CCR4, CAF1, NOT1 through 5, CAF40 and CAF130. 
Interestingly, it has recently been reported that CCR4-NOT complex is also involved in 
mRNA deadenylation, the first step of mRNA decay. Of those nine components, CCR4 
and CAF1 were identified as the major deadenylase complex and when inactivated,
9
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intracellular deadenylation processes were severely damaged (Tucker et al., 2001 & 
2002; Chen et al., 2002).
4.1.CCR4
Yeast CCR4 protein has sequence homology to a family of Mg2+-dependent 
nucleases related to E. coli exonuclease III in its C-terminal domain. Deletion of the 
CCR4 gene causes a decrease in the rate of deadenylation and a concomitant stabilization 
of mRNAs (Tucker et al., 2001). Point mutations in highly conserved key catalytic amino 
acids cause a similar deadenylation defect, demonstrating that the catalytic activity o f the 
protein is required for deadenylation (Chen et al., 2002; Tucker et a l, 2002). Drosophila 
ccr4 mutants also have a deadenylation defect (Temme et al., 2004). Both yeast CCR4 
and it mammalian homo log are active as poly(A)-specific 3’-exoribonuclease in vitro in 
the absence of the other subunits of the CCR4-NOT complex (Chen et al., 2002; 
Viswanathan et al., 2003). In addition to it C-terminal nuclease domain, CCR4 contains a 
conserved leucine-rich repeat domain which is essential for binding the CAF1 and also 
affects exonuclease activity (Clark et al., 2004).
4.2. CAF1
Yeast CAF1 (yCAFl) is a 49-kDa protein and a member of the RNase D family 
of exonuclease (Daugeron et al., 2001; Moser et al., 1997). It has been reported that the 
C-terminal ribonuclease domain of yeast CAF1 overexpressed and purified from E. coli 
displayed deadenylase activity with some poly(A) preference (Daugeron et al., 2001; 
Thore et al., 2003). Deletion of yeast CAFl gene leads to a similar deadenylation defect
as a ccr4L mutation (Daugeron et al., 2001; Tucker et al., 2001). Mouse CAF1
10
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(mCAFl) also display deadenylase activity and mutation of putative key, catalytic 
residues in the RNase D domain inactivates mCAFl activity (Viswanathan et al., 2004). 
Similarly, inactivation of Drosophila CAF1 causes an increased steady-state poly(A) tail 
and a decrease in the rate of HSP70 mRNA deadenylation (Temme et al., 2004).
5. Aim of this dissertation
The aim of this dissertation is to characterize the functional roles of yCAFl in 
deadenylation and other possible processes. While yCAFl is known to be the major 
component of deadenylase complex, its overall function to the deadenylation has not 
been characterized well. More importantly, our previous in vitro and in vivo experiments 
concerning deadenylase function of yCAFl showed that it may not contain deadenylase 
activity. Several previous observations also support our observations. First, .the catalytic 
domain of yCAFl is not well conserved (Moser et al., 1997). Second, although yeast 
strains completely lacking CAF1 show a defect in deadenylation, strains containing a 
full-length but catalytically inactive CAF1 show no phenotype (Tucker et al., 2002; Chen 
et al., 2002; Thore et al., 2003). Third, in vitro deadenylase activity of yCAFl is CCR4 
dependent (Tucker et al., 2001). Fourth, overexpression of CCR4 can rescue the 
deadenylation defect of cafl, but overexpression of CAF1 does not compensate for that 
of ccr4 (Tucker et al., 2001). Since deadenylation is the first rate-limiting step of mRNA 
degradation, the dissection of the functional properties of CAF1 will shed light on the 
mechanisms by which the rate of mRNA decay is modulated.
11
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Pathways for mRNA decay in eukaryotes 
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Figure 1. Eukaryotic mRNA decay pathways (modified from Beelman and Parker, 
1995). Deadenylation-dependent decay pathway can lead to decapping and 5’-3’ 
exonucleolytic cleavage or to 3’ to 5’ decay mediated by exosome. All eukaryotic 
mRNAs may be subjected to this pathway unless they are targeted for rapid 
deadenylation-independent decay pathways by a early stop codon. After deadenylation- 
independent decapping, mRNA is degraded in a 5’ to 3’ direction. Endonucleolytic 
cleavage of mRNA may serve as a one-step deadenylation that leads to decapping and 5’ 
to 3’ decay and, c-myc, c-fos, and IGF-II are known to be subjected to this pathway.
12
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Figure 2. Detailed diagram of deadenylation dependent decay pathway (modified 
from Coller and Parker, 2004).
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CHAPTER I
FUNCTIONAL ANALYSIS OFCAF1 PROTEIN 
Introduction
In eukaryotes the major pathway of mRNA degradation is initiated by poly(A) 
tail shortening (deadenylation) followed by removal of the 5’ cap structure (decapping) 
and 5’ to 3’ exonucleolytic cleavage of the mRNA body by the XRN1 exonuclease 
(Parker and Song, 2004; Beelman and Parker, 1995; Wilusz et al., 2001). Deadenylation 
as compared to decapping and 5’-3’ nuclease digestion has been shown to be most 
important in the control of mRNA degradation rates (Cao and Parker, 2001). The CCR4- 
NOT complex in responsible for the majority of the poly(A) shortening process in yeast 
(Tucker et al., 2002 & 2001; Chen et al., 2002), and the 1.0 MDa core complex is 
comprised o f ten components: CCR4, CAF1 (also known as POP2), five NOT proteins 
(NOT1-NOT5), CAF40, CAF130 and BTT1 (Liu et al., 1998; Bai et al., 1999; Chen et 
al., 2001; Denis and Chen, 2003). Of these proteins, CCR4 and CAF1 appear to be the 
most important players in the mRNA deadenylation process (Tucker et al., 2002 & 2001).
The CCR4 protein as a member of ExoIII family of nucleases/phosphatases 
(Dlakic, 2000; Dupressoir et al., 1999) is the catalytic subunit responsible for 
degradation of the mRNA poly(A) tail, and point mutations in the predicted active site of 
CCR4 cause deadenylation defects like that of a ccr4 deletion (Chen et al., 2002; Tucker
14
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et al., 2002). Similarly, a ccr4 deletion mutant in Drosophila also displayed an in vivo 
deadenylation defect (Temme et al., 2004).
The role of the CAF1 protein, however, is less clear. Its principal role has been 
considered to be that of linking CCR4 to the remainder of the CCR4-NOT complex (Liu 
et al., 1998; Bai et al., 1999; Draper et al., 1995). Deletion of the CAF1 gene showed a 
dramatic deadenylation defect in vivo, albeit to a lesser extent than that of ccr4 (Tucker 
et al., 2001), and this has been interpreted to mean that CCR4 must be part of the CCR4- 
NOT complex to function well in vivo. Although CAF1 is classified as a member of the 
DEDDh family of nucleases (Moser et al., 1997; Zuo and Deutscher, 2001) and the 
polypeptide isolated from E. coli is active as a 3’ to 5’ exonuclease with some preference 
for poly(A) sequences, inactivation of predicted key catalytic active sites of CAF1 did 
not affect in vivo deadenylation function (Viswanathan et al., 2004). Moreover, 
overexpression of CCR4 could partially complement the deadenylation defect of a cafl 
deletion, but overexpression of CAF1 did not rescue phenotypes associated with that of a 
ccr4 deletion (Tucker et al., 2001; Chen et al., 2002). While these results indicate that the 
deadenylase activity of CAF1 is not required for its in vivo deadenylation function, other 
evidence argues also against CAF1 functioning solely to link CCR4 to the remainder of 
the CCR4-NOT complex. For instance, defects in other NOT components do not result in 
deadenylation defects to nearly the same degree as that of a cafl deletion (Tucker et al.,
2001). A cafl deletion is also lethal with deletion of the decapping/translational regulator 
DHH1 (Coller and Parker, 2005), whereas a ccr4 deletion is not (Maillet and Collart,
2002). Moreover, cafl has been shown to partially suppress translation stress effects in a 
manner similar to that of decapping defects whereas ccr4 does not display this behavior 
(Holmes et al., 2004). These observations suggest roles of CAF1 in both deadenylation
15
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and non-deadenylation processes.
Since the predicted catalytic sites of CAF1 are not critical to its in vivo function, 
understanding the functional roles of CAF1 on mRNA turnover will require the 
identification of other important regions of the CAF1 protein. To identify in the CAF1 
protein functional regions which are critical for mRNA degradation, we conducted a 
deletion analysis of yeast CAF1 by targeting regions absolutely conserved among CAF1 
orthologs. We demonstrate four important results in this report. First, we identify four 
functional regions of CAF1, including those required for binding CCR4 and for 
deadenylation. Second, we find that the domains of CAF1 that are most important for 
deadenylation in vivo are distinct from the region that is required for CCR4 binding or 
CAF1 catalysis, implying that CAF1 function is not primarily limited to simply linking 
CCR4 to the remainder of the CCR4-NOT complex. Third, defects in CAF1 but not that 
CCR4 appear to affect translation and to interact genetically with other factors 
controlling translation. Fourth, a cafl deletion when coupled with a PAB1 translation 
defect that does not by itself or when coupled with ccr4 affect deadenylation severely 
reduces deadenylation. These results implicate CAF1 in communications with translation 
that also affect the deadenylation process.
16
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Materials and Methods
Yeast strains and growth conditions.
The background yeast strains used in this study are listed in Table 1. Yeast 
strains were grown in YEP medium (2% yeast extract, 1% Bacto Peptone) or minimal 
medium supplemented with nutrients required for auxotrophic deficiencies and with 4% 
glucose or 2% galactose/2% raffinose unless otherwise indicated. YD plates consisted of 
YEP medium supplemented with 2% glucose and 2% agar and caffeine plates are YD 
plates with either 5, 8, or 15 mM caffeine.
Site-directed deletion mutagenesis.
The MPTO plasmid harboring the yeast CAF1 open reading frame was used as 
the template for the polymerase chain reaction (PCR). All PCR reactions were performed 
with Vent polymerase (New England Biolabs). In order to generate 173DVW175, 
213FRS215, 255WQF257, 303SGL305, 329LMN331, and 340DFE342 deletions, we 
designed the following six pairs of oligonucleotide primers: ca fl-l-f  (5’- 
TATCTTTTCGTTCGCAAGTCCAACCTTTACAGTGAATTC-3’) and cafl-l-r (5’- 
GTAAAGGTTGGACTTGCGAACGAAAAGATAATTTGGGG-3’), cafl-2-f (5’- 
AGGCCGATCGGCACTAAGGTCGATTACCACTATCAGACA-3’) and cafl-2-r (5’- 
GTGGTAATCGACCTTAGTGCCGATCGGCCTAGCCAAAGT-3’), cafl-3-f (5 
AACGGTCCCTCAACGAATTTTGAATTTGACCCAAAGAAG-3’) and cafl-3-r (5’- 
GTCAAATTCAAAATTCGTTGAGGGACCGTTGTCAGGCTT-3 ’), cafl -4-f (5 
C AGCTTCTAAT GG AC ATGAT GGAT GATT CT GTTACTT GG-3 ’) and cafl-4-r (5’-
17
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AGAATCATCCATCATGTCCATTAGAAGCTGCGAAAATTC-3’), cafl-5-f (5’- 
TTCCT G ATC A AC ATT GACTCC AT GCCC AAC A AC AAGG AG-3 ’) and cafl-5-r (5’- 
GTTGGGCATGGAGTCAATGTTGATCAGGAAACCTAGATC-3’), and cafl-6-f (5’- 
CCCAACAACAAGGAGTGGTGGGTCCATCAATACATGCCC-3’) and cafl-6-r (5’- 
TTGATGGACCCACCACTCCTTGTTGTTGGGCATGGAGTC-3 ’). These primers are 
used for the first PCR reaction in combination with BamHI and Hindlll restriction site 
introduced Cafl -Bm-f (5 ’ - AAAGGAT CC ATGC AAT CTAT GA AT GTAC A A) and 
cafl/2291-Hind (5’-TACATATAAAGCTTAAATGATCATTGGTCCC-3’) primers. The 
first PCR products were used for amplifying final full length CAF1 mutant alleles using 
Cafl-Bm-f and cafl/2291-Hind primers. The final PCR products were purified, digested 
with BamHI and Hindlll, and inserted into BamHI and Hindlll- digested pET-23a(+) to 
generate plasmids pTB8a (CAF1), pTB8-l (cafl-1), pTB8-2 (cafl-2), pTB8-3 (cafl-3), 
pTB8-4 (cafl-4), pTB8-5 (cafl-5), and pTB8-4 (cafl-<5), respectively. All the sequences 
of the mutagenized CAF1 alleles were verified by sequencing. For further analysis CAF1 
open reading frames were subcloned into pLexA202-2 (Cook et al., 1994), pGEX-KG, 
pJG4-5 (Cook et al., 1994), and pJCN112 (Chen et al., 2002) to make N-terminal LexA, 
GST, HA, and N-terminal Flag with C-terminal 6His epitope tagged CAF1 proteins, 
respectively.
Library screening
Strain 319-cl-IN (caflA pablA ) carrying pYC360 (PAB1 CEN URA3) and 
pYC506 (pabl-ARRM2 TRP1) was transformed with a YEpl3 (2pm LEU2) high-copy- 
number yeast genomic library and plated on synthetic drop-out media lacking uracil, 
leucine, and tryptophane for selecting transformants. Approximately 15,000 Leu+
18
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colonies were subsequently replica plated onto minimal media containing 5-fluoroorotic 
acid (5-FOA). The plasmids from yeast capable of growing on FOA plates were rescued, 
transformed into E. coli DH5a, and analyzed by colony PCR and restriction digestion to 
identify YEpl3 based plasmids. The selected plasmids were retransformed into the 
original yeast strain to confirm the high-copy-number suppression of the pabl-ARRM2 
cafl synthetic lethality. The yeast genome segments containing suppressor genes were 
identified by sequence analysis.
Flag pull-down analysis
The yeast cultures containing FLAG-CAF1 fusions were grown to late log phase 
in 50 ml selective media supplemented with 4% glucose, shifted to 100 ml of the same 
media with 2% glactose/raffinose and grown for 16 hours. The cells were washed and 
lysed in extraction buffer (50 mM Tris-Cl [pH7.9], 150 mM NaCl, 0.1 mM MgCh, 0.1% 
NP40, 20% glycerol) plus a protease inhibitor cocktail. After clarification of the crude 
cell lysate by centrifugation at 15,000 x g at 4°C for 15 min twice, the supernatants were 
incubated with 400 pi of anti-FLAG M2 affinity agarose (Sigma) at 4°C overnight. The 
bound resins were washed with 10 ml wash buffer (extraction buffer with 5% glycerol) 
three times, transferred to eppendorf tubes and washed with 1 ml wash buffer five times. 
The resultant precipitates were run subsequently on an 8% SDS-polyacrylamide gel, 
electro-transferred to polyvinylidene fluoride (PVDF) membrane (Immobilon™-P, 
Millipore) and analyzed by Western blot using SuperSignal® West Pico 
Luminol/Enhancer Solution (Pierce).
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Protein extraction, in vitro deadenylation assay, and in vivo translation assays.
FLAG-CCR4 protein purification was performed as described previously with 
some modifications (Viswanathan et al., 2003). Briefly, the EGY188-cl-la-l cells 
harboring single copy of CCR4 (pYC343) and the LexA-CAFl fusion variants were 
grown in 1 liter of selective medium with 4% glucose to mid-log phase (O D 6oo of 0.7). 
The cells were harvested, washed once with pure water and lysed in Buffer A (50 mM 
Tris-Cl [pH 7.9], 150 mM NaCl, 0.1 mM MgCl2, 0.1% NP40, 10% glycerol) 
supplemented with protease inhibitors. After clarification of the crude lysate by 
centrifugation (15,000 x g at 4°C for 20 min), the supernatants were incubated with pre­
equilibrated anti-FLAG M2 antibody-agarose (Sigma) at 4°C for 4 h. After washing of 
the FLAG agarose beads with 10 ml of washing buffer (bufferA with 5% glycerol) three 
times, the FLAG fusion proteins were eluted twice with buffer A containing 200 pg/ml 
FLAG peptide (Sigma). In vitro deadenylation assays were conducted as described 
(Viswanathan et al., 2003 & 2004). The rates of in vivo protein synthesis were 
determined by quantitating the amount of [ S]-methionine incorporation into protein as 
described (Schwartz and Parker, 1999).
RNA preparation and analyses.
RNA samples were prepared using the hot acidic phenol method described in 
(Cook and Denis, 1993). Yeast cells were resuspended in TES (10 mM Tris-Cl [pH7.5], 
10 mM EDTA, 0.5% SDS) and acid phenol and incubated at 65 °C for 45 min with 
frequent vortexing. The lysates were then purified with acid phenol and chloroform. 
Total RNA was then precipitated with alcohol and dissolved in DEPC water.
To perform the transcriptional pulse-chase experiments, strain EGY188-cl
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carrying the individual LexA-cafl variants was grown in 5 ml synthetic media 
supplemented with 2% raffinose, transferred and regrown in the 100 ml fresh media until 
mid-log phase (ODeoo of 0.7). Cells were then harvested, washed once with fresh media 
and transferred to 15 ml of fresh media containing 2% raffinose and grown for 15 min. 
GAL1 transcription was activated by adding galactose at a 2% final concentration for 15 
min and shut off by adding glucose to a concentration of 4%. Since yeast cells harboring 
the LexA-cafl-2 protein resulted in poor GAL1 transcription, the GAL1 promoter was 
activated for 30 minutes prior to transcription shut off.
The deadenylation rates and end points for GAL1 mRNA were determined 
following RNase H treatment of purified RNAs as described previously (Muhlrad and 
Parker, 1992). An oligonucleotide probe (5’-GCCATTTGGGCCCCCTGG-3) 
complementary to a segment 133 bp upstream of the GAL1 translational stop codon was 
hybridized with 12-20 pg of total RNA prior to RNase H digestion. The resultant GAL1 
3 ’ polyadenylated species were separated on a denaturing polyacrylamide gel (6%/7.5 M 
urea) and detected by Northern analysis using a probe complementary to the 3 ’ end of the 
GAL1 mRNA (5’-
GCCC AAT GCT GGTTTAGAG ACGAT G ATAGC ATTTTCTAGCT C AGC AT C AGTGAT 
CTTAGGG-3). The rate of deadenylation was determined for the shortest poly(A) tail as 
previously described (Tucker et al., 2001; Viswanathan et al., 2004).
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Table 1. List of yeast strains
Strain Genotype
EGY188 MATa ura3 his3 trpl LexA-LEU2
EGY188-cl Isogenic to EGY188 except cafl::URA3
EGY188-cl-l Isogenic to EGY188 except cafl::ura3
EGY188-la-l-cl Isogenic to EGY188 except ccr4::ura3 cafl::LEU2
EGY191 MATa ura3 his3 trpl LexA-LEU2
EGY191-cl Isogenic to EGY191 except cafl::URA3
KY803-cl MATa Ieu2-PET56 trpl-Al ura3-52 gal2 gcn4-Al cafl::LEU2
AS319/YC504 MATa ura3leu2 his3 trplpabl::HIS3 [PAB1-TRP1]
AS319-1 a-uN/YC504 Isogenic to AS319 except ccr4::ura3::NEO
AS319-C1-1N Isogenic to AS319 except cafl::leu2::NEO
AS319-cl-IN/YC505 Isogenic to AS319-cl-lN except [PAB1-ARRM1-TRP1] 
[PAB1-URA3]
AS319-cI-lN/Y C506 Isogenic to AS319-cl-lN except [PAB1-ARRM2-TRP1] 
[PAB1-URA3]
AS319-dl-uL/Y C504 Isogenic to AS319 except dhhl::ura3::LEU2
1881/YC504 Isogenic to AS319 except cdc33-l
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Results
Purified yeast CAF1 does not display RNase function in vitro
It has been reported that C-terminal exonuclease domain of yeast CAF1 purified 
from E. coli showed deadenylase function in vitro with a poly(A) preference (Thore et al., 
* 2003). In order to verify the enzymatic function of the CAF1 protein, we constructed a 
full length CAF1 with a FLAG tag at its N-terminal end. Upon transformation into a ccr4 
cafl double deletion strain, we purified FLAG-CAF1 fusion protein utilizing a one-step 
affinity chromatography. Due to a strong interaction with CCR4, which has been verified 
as the major deadenylase, we had to use ccr4 cafl double knockout strain in order to 
avoid copurifying CCR4 enzymatic activity. Purified FLAG-CAF1 protein sample was 
then assayed for it enzymatic activities on a 25N+20A synthetic ssRNA substrates.
As shown in Figure 3, purified CCR4-FLAG displayed strong deadenylase 
activity as reported (Chen et al., 2002). In contrast, purified FLAG-CAF1 failed to 
function as a deadenylase. The ccr4-l-FLAG mutant protein (E556A) mutated in a key 
catalytic amino acid in exonuclease domain was used as a control and failed to function 
as deadenylase as expected (Chen et al., 2002).
The deadenylase function of yeast CAF1 is not required in vivo
Although yeast CAF1 has been shown to display deadenylase functions in vitro, 
this deadenylase function of CAF1 could not be assessed by our in vitro enzyme assay 
with purified N-terminal FLAG tagged CAF1 protein from ccr4 cafl double knock-out 
strain. We determined subsequently whether the putative enzyme activities of yeast 
CAF1 were required in vivo. LexA-yCAFl proteins were created containing either the
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Figure 3. Yeast CAF1 does not display deadenylase activity in vitro. N-terminal 
FLAG tagged yeast CAF1 proteins are overexpressed and purified from ccr4 cafl double 
knock-out strain (see “Materials and Methods”). Purified CCR4-FLAG and ccr4-l- 
FLAG proteins were used as the positive and negative control, respectively. Radiolabeled 
25N+20A RNA substrates were incubated with equivalent amounts of the three proteins 
at time zero for the times indicated.
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S199A/E201A alteration that inactivated yCAFl deadenylase function in vitro (Thore et 
al., 2003), which is comparable to the D39A/E41A mutation in mCAFl that blocked its 
deadenylase activity. The expression of LexA-yCAFl (S199A/E201A) and Lex A-yCAFl 
(Y320A/D321A) completely complemented the caffeine sensitivity of the yeast cafl 
deletion as did a Lex A- yCAFl protein (Viswanathan et al., 2004), suggesting that the 
enzymatic function of CAF1 is not required for its in vivo function.
We additionally analyzed the ability of LexA-yCAFl (S199A/E201 A) to allow 
deadenylation of the GAL1 mRNAs in vivo. GAL1 mRNA is polyadenylated at two 
locations 110 nt apart (Miyajima et al., 1984; Cui and Denis, 2003). Following the 
induction of GAL1 mRNA synthesis for 12 min with galactose and repression at time 
zero with glucose, the rate of deadenylation of the two GAL1 mRNAs was followed in a 
cafl strain containing LexA-yCAFl, LexA-yCAFl (S199A/E201 A), or LexA. LexA- 
yCAFl allowed an efficient deadenylation of both GAL1 long and GAL1 short mRNA 
(Fig. 4), and CCR4 deadenylated the two mRNAs at rates of 4.7 and 3.4 A’s/min, 
respectively. In contrast, in a cafl background expressing only LexA, deadenylation was 
slowed for both mRNA (rates of 1.9 and 1.3 A’s/min, respectively). Incomplete 
deadenylation was also observed at late times in the cafl background (Figure 4) in 
agreement with previous observations that cafl causes a deadenylation end-point defect 
(Tucker et al., 2001). In contrast, the cafl /LexA-yCAFl (S199A/E201A) strain 
deadenylated both GAL1 mRNAs at comparable rates and to similar extents as that 
observed with LexA-yCAFl (Fig. 4, rate of deadenylation for GAL1 long was 4.4 
A’s/min and for GAL1 short was 2.7 A’s/min). These data indicate that the yCAFl 
deadenylase function is not required in vivo in the deadenylation process.
We also tested whether the deadenylase function of mCAFl the deadenylase
25
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Figure 4. Mutations that inactivate yCAFl deadenylase function in vitro do not 
affect deadenylation of GAL1 in vivo. A, strain EGY188-cl expressing LexA-yCAFl, 
LexA-yCAFl (S199A/E201A), and LexA was subjected to pulse-chase analysis to 
determine the rates at which GAL1 mRNA deadenylated in vivo. Following an 12-min 
induction of the GAL1 gene with galactose, its transcription was shut off at time zero 
with glucose, and RNA samples were taken at the times indicated. dT refers to the 
addition of oligo (dT) and RNase H to remove the poly(A) tail. B, the graphical summary 
of the average 2-3 determinations is represented with ± S.E.M. as indicated.
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function of mCAFl was required for complementing a cafl deletion. A yCAFl/mCAFl 
fusion (carrying the unique N-terminal of yCAFl and the DEDDh domain of mCAFl) 
was used for this analysis, because it gives better complementation than does mCAFl 
alone (Shimizu-Yoshida et al., 1999). We found that mCAFl mutations (D39A/E41A and 
Y159A/D160A), which inactivated mCAFl in vitro, like similar mutations in yCAFl, 
did not interfere with the ability of yCAFl/mCAFl hybrid protein to complement the 
caffeine sensitivity of a cafl deletion (Viswanathan et al., 2004).
Mutagenesis of CAF1 in the regions that are highly conserved among CAF1 orthologs
In order to identify CAF1-specific functional regions we targeted for 
mutagenesis the regions of CAF1 that are common only to CAF1 ortho logs and are not 
present in any other DEDDh nuclease family members (Zuo and Deutscher, 2001; Moser 
et al., 1997). Six regions were identified as absolutely conserved among CAF1 ortho logs 
(Figure 5B). Three amino acid deletions were made in each case to remove the region of 
homology, resulting in cafl alleles 1 through 6. After these deletions were constructed 
and their phenotypes were obtained, the X-ray crystallographic analysis of the C-terminal 
RNase D domain of CAF1 protein was published (Thore et al., 2003). The relative 
locations o f each of the constructed cafl alleles are shown in Figure 5A: cafl-1 
(173DVW175) and cafl-3 (255WQF257) alleles are positioned in p-sheets p i and P3 
that hydrogen bond to each, cafl-2 (213FRS215) is located between p2 and a3 in a 
crystallographically undefined loop region, and cafl-4 (303SGL305), cafl-5 
(329LMN331), and cafl-6 (340DFE342), are located between a6  and P5, between a7 
and a8, and on a.8, respectively.
Each of the cafl mutant alleles was subsequently cloned into various kinds of
27
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173DVW175 213FRS215 255WQF257 303SGL305 329LMN331 340DFE342
caf1-1 caf1-2 caf1-3 caf1-4 caf1-5 caf1-6
N
Figure 5. Mutagenesis of CAF1.
(A) Location of CAF1 mutations are illustrated on the three-dimensional structure of the 
nuclease domain of the CAF1 protein (Thore et al., 2003).
(B) The six absolutely conserved regions targeted for mutagenesis are composed of three 
amino acids each as indicated above the schematic representation of CAF1 and are 
located in regions separate from the putative four key catalytic amino acids conserved 
among DEDDh ribonucleases (black arrows). The names of the mutant alleles are also 
shown beneath the deleted amino acids.
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Figure 6. Western blot analysis of N-terminal HA epitope tagging CAF1 mutant 
proteins. The HA-CAF1 proteins were expressed in the EGY191-cl strain, extracted and 
subjected to Western analysis. The apparent increased abundance of cafl-2 protein in the 
gel that is presented is artifactual and no significant differences in the abundance of these 
proteins was observed in other experiments (see also Figure 7).
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plasmid vectors such as pLexA(202), pJG4-5 (HA-tagged), and pJCN112 (FLAG- 
tagged) for further analysis (see Materials and Methods). Each of the mutant proteins 
was expressed to comparable levels as that found for the wild-type CAF1 protein, 
indicating that these small deletions did not affect the protein expression or stability of 
CAF1 (Figure 6; data not shown).
cafl-1. -3. and -6 alleles display similar phenotypes to a cafl null allele
One of the most prominent phenotypes of a strain carrying a cafl deletion is its 
caffeine sensitivity, although other phenotypes such as temperature sensitivity and slow 
growth have been observed (Sakai et al., 1992; Draper et al., 1995; Hata et al., 1998). To 
examine the phenotypes of CAF1 mutant alleles, we tested the growth phenotypes of the 
cafl alleles by using the EGY188-cl (cafl) strain carrying a plasmid expressing an N- 
terminal LexA fusion with each of the mutant CAF1 proteins (Table 2). Of the six CAF1 
mutants, cafl-1, cafl-3 and cafl-6 alleles resulted in an inability to grow on YD plates 
containing 8 mM caffeine. Interestingly, the cafl-1 and cafl-3 alleles showed a dominant 
negative growth defect as their growth rate was observed to be slowed as compared to 
that of the cafl null allele (data not shown). The cafl-2 and cafl-5 alleles displayed only 
weak sensitivity to caffeine, and for the cafl-4 allele, we did not observe any difference 
in growth on caffeine plates as compared to the wild-type strain (Table 2).
Wild-type, cafl-4, and cafl-5 alleles were able to grow partially at 41°C (Table 2), 
whereas the cafl-1, -2,-3, and -6 alleles, like the cafl deletion, failed to grow at 41 °C. In 
order to verify that the three amino acid deletions we constructed did not dramatically 
affect the structure of the protein and therefore were the cause for the caffeine and 
temperature sensitivity phenotypes that were observed, we constructed two additional
30
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Table 2. Growth phenotype test of yeast cells carrying cafl mutant alleles





ca fl-4 ++ w
cafl-5 + w
cafl-6 - -
cafl A - -
cafl-10 w -
cafl-11 -
EGY188-cl strains carrying LexA-CAFl proteins or pLexA(202) vector alone (caflA) 
were tested. Growth was detected on YEP plates containing 4% glucose (YD) and 
supplemented with 8 mM caffeine. Temperature sensitive growth was monitored on YD 
plates at 41°C. ++, strong growth; +, good growth; w, weak growth; no growth.
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cafl alleles in which three alanine residues were substituted for the three residues deleted 
in cafl-2 and cafl-3. These two alleles were chosen in that results shown below indicated 
that the cafl-1 and cafl-6 alleles appeared phenotypically similar to cafl-3, and cafl-2 
was unique for being defective in CCR4 binding, cafl-10 (213AAA215) and cafl-11 
(255AAA257) displayed the exact same phenotypes as their respective deletion alleles, 
cafl-2 and cafl-3 (Table 2). For the remainder of our analysis the original deletion 
mutations were used.
The cafl-2 protein is defective in binding with CCR4
The relative locations of the proteins in the CCR4-NOT core complex have been 
determined (Bai et al., 1999; Chen et al., 2001; Denis and Chen, 2003) in which the 
CAF1 protein is critical for linking CCR4 to the remainder of the CCR4-NOT complex. 
We, therefore, assessed the ability of each of the CAF1 mutant proteins to bind CCR4, 
using FLAG-tagged CAF1 protein variants expressed in a cafl deletion background. 
After FLAG immunoprecipitations were conducted, as shown in Figure 7, we found that 
the ca fl-4 protein was able to bind CCR4 as well as wild-type CAFl. The cafl-2 protein, 
in contrast, was totally defective in binding to CCR4 (Figure 7). While the cafl-1, -3, -5, 
and -6 proteins displayed reduced binding to CCR4, they still displayed significant 
association with CCR4. All of the mutant proteins were still capable of binding NOT1, 
although they did appear to display reduced binding to NOT1 as compared to wild-type. 
These results suggest several conclusions. First, they indicate that the differences in the 
growth and caffeine phenotypes described above do not result from differences in CAF1 
binding NOT1. Second, and most importantly, the severe phenotypes displayed with the 
cafl-1 , -3, and -6 alleles was not due to loss of CCR4 binding, as each of the proteins
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Figure 7. cafl-2  fails to contact CCR4 in vivo. N-terminal FLAG tagged CAF1 alleles 
were transformed into a cafl deletion strain, KY803-cl. Crude extracts (5 mg) were 
immunoprecipitated with anti-FLAG M2 antibody and proteins were visualized by 
Western blot analysis with antibodies directed against CCR4, N0T1, and CAF1 as 
indicated.
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could bind CCR4 as well as cafl-5 which did not display as severe growth defects. Third, 
the cafl-2 protein was completely defective for binding CCR4 and yet the cafl-2 strain 
grew better than did cafl-1, -3, or -6, indicating that loss of CCR4 binding alone was not 
the cause for the cafl deletion phenotypes. Fourth, the ratio of NOT1 to CCR4 in the 
cafl-1, -3, -5, and -6 immunoprecipitations was similar to that found in the wild-type 
strain, arguing that the CCR4-NOT complex remained intact, albeit probably less 
abundant in the presence of these cafl alleles.
The ability of CAF1 to bind CCR4 is not required for CCR4 deadenylation function in 
vitro
Immunoprecipitation studies showed that cafl -2 is totally defective in binding with 
CCR4 and the remaining cafl mutants showed that they were still capable of binding to 
CCR4. In order to identity if the interaction between CCR4 and CAF1 affects the CCR4 
deadenylation function in vitro, we performed enzyme assays with radiolabeled 
25N+20A synthetic RNA substrate (Figure 8A). For this experiment, N-terminal FLAG 
tagged single copy CCR4 and CAF1 mutant alleles were transformed into a ccr4A cafl A 
background. CCR4 proteins were subsequently purified by using affinity 
chromatography and equivalent amounts of CCR4 were used in the in vitro 
deadenylation reactions (Figure 8B). The relative rate of deadenylation from each 
reaction were quantified by using Phosphorimager software and normalized by setting 
wild-type reaction to 100. As shown in Figure 8 and Table 3, there is no effect of the cafl 
alleles on in vitro CCR4 deadenylation. For example, CCR4 from cafl -2, showed almost 
no difference in deadenylation function as compared to CCR4 purified from wild-type. 
While CCR4 from cafl-1, cafl-3, and cafl-6 that still have residual binding function to
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CAF1 cafl-1 cafl-2 cafl-3 cafl-4 cafi-5 caff-6  LexA Buffer
Time (min) 0 5 16 30 Q S 15 30 0 5 15 30 0 S 15 30 0 S 15 30 0 5 15 30 0 5 15 30 0 5 15 30 0 5 15 30
25N+20A- f * i i  «•» ***
* * # f c
CCR4
Figure 8. CAF1 binding to CCR4 does not affect the deadenylase function of CCR4 
in vitro. (A) Deadenylation assays with single copy FLAG-CCR4 fusion protein purified 
from the yeast cells containing cafl mutant alleles. Radioactively labeled synthetic 
25N+20A RNA substrates were incubated with purified CCR4 protein and removed at 
each time point. The removed samples were subsequently separated on a 15% 
polyacrylamide, 8 M urea gel and visualized by a Phospholmager. The length o f the 
RNA substrate is indicated on the left. (B) Purified FLAG-CCR4 proteins from each of 
the cafl mutants were visualized by Western blot analysis. Equivalent amounts of 
FLAG-CCR4 protein were used in deadenylation assay (A).
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Table 3. Relative deadenylation rates of CCR4 isolated from cafl mutant alleles









[32P] labeled 25N+20A synthetic RNAs were used as the substrate. The reaction products 
were subjected to polyacrylamide denaturing gel electrophoresis as described in Figure 8 
and the Materials and Methods, and analyzed and quantified by a Phosphor imager and 
its software (Bio-Rad). The deadenylation rate o f CCR4 from the wild-type strain was set 
at 100.
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CCR4 (Figure 3), they displayed about the same activity as compared to cafl-2. This 
result suggests that, at least in vitro, the CCR4 and CAF1 interaction is not necessary in 
the deadenylation process and the dominant negative in vivo phenotype showed with 
cafl-1 is not due to a poisoning of CCR4 deadenylation activity.
Identification of separable functional regions required for mRNA deadenylation
In order to determine if the cafl mutant alleles affected mRNA deadenylation in 
vivo, transcriptional pulse-chase experiments were performed on the GAL1 mRNA. In 
this experiment, transcription of GAL1 mRNA was induced by adding galactose and then 
repressed by adding glucose to the growing culture. Following a 15 minute induction, 
GAL1 mRNA synthesis was shut off at time zero and aliquots were prepared for Northern 
analysis at each time point. As shown in Figure 9A, GAL1 mRNA was shortened with a 
3’ oligonucleotide probe and RNase H prior to separation on a denaturing 
polyacrylamide gel for size resolution of the poly(A) tail. Due to the two polyadenylation 
sites in the GAL1 gene, long and short GAL1 mRNAs (GAL1-L & -S) can be analyzed 
simultaneously (Miyajima et al., 1984; Cui and Denis, 2003). The GAL1-L has an 
additional 110 nt in its 3’-UTR segment as compared to GAL1-S (Figure 9A). These two 
mRNA, also display different rates of deadenylation (Cui and Denis, 2003), allowing us 
to analyze the effect of the cafl alleles on differentially deadenylated mRNAs. For this 
experiment LexA fusions to the CAF1 variants were used to transform a cafl deletion 
yeast strain.
The deadenylation rate and endpoint analysis of GAL1 mRNA identified three 
functional regions that are important for normal deadenylation in vivo. Of the six cafl 
alleles, cafl-1, cafl-3, and cafl-6 alleles displayed severe deadenylation defects similar
37
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Figure 9. Mutagenesis of CAF1 identities separable functional regions involved in 
deadenylation.
(A): Diagram for the GAL I gene and its two mRNAs.
(B): Transcriptional pulse-chase analyses on GAL1 mRNA were conducted with 
EGY188-cl harboring each LexA-cafl fusion or the LexA vector as the negative control. 
Following a 15 to 30-min induction of the GAL1 gene by addition of galactose, 
transcription was shut off at time zero by adding glucose. Northern blot analyses were 
conducted with RNA samples prepared from yeast cells harvested at the time points 
indicated. dT refers to the RNA sample probed with oligo (dT) followed by RNase H 
digestion to remove the poly(A) tail.
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Wild-type 4.3±0.7 3.6±0.2 11±1.9
cafl-1 1.7±0.1 2.5±0.05 2913.4
cafl-2 3.4±0.7 2.8±0.04 1512.1
cafl-2 1.8±0.2 2.2±0.5 2913.4
cafl-4 5.0±0.5 4.4±2.0 1112.1
cafl-5 3.6±0.2 2.210.5 1214.3
cafl-6 2.4±0.2 2.7±0.5 2412.0
cafl A 2.4±0.5 1.9±0.3 2612.7
cafl deletion strains (EGY188-cl) harboring LexA version of wild-type, cafl mutants, 
and vector-self (pLexA202-2) were used for transcriptional pulse chase analysis. Rates of 
deadenylation were measured by the change in the length of the shortest poly(A) tail as a 
function of time following transcriptional shut-off (Figure 4B). EGY188-cl-l strains 
harboring LexA-cafl variants and pRP485 {GAL\-MFA2pG) were used for analyzing 
steady state MFA2pG mRNA. Longest pG  fragments from Northern analysis were taken 
for deadenylation endpoint measurements. All values represent the average o f three 
separate experiments and the standard error of the mean (SEM).
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to that displayed with a cafl null allele. For the wild-type strain (Figure 9B), GAL1-L 
poly(A) tails were shortened to 8-12 nt within 9 min and for those of GAL1-S in 12 min. 
In contrast, the cafl-1, -3, and -6 alleles failed to deadenylate completely even after 40 
min for both GAL1-L and -S (Figure 9B). The average rates of deadenylation for GAL1-L 
and GAL1-S inwild-type were 4.3 and 3.6 A’s/min, respectively (Table 4). In the cafl-1, - 
3, and -6 mutated strains, the range of the deadenylation rates for the long and short 
GAL1 mRNAs were from 1.7 to 2.4 and from 2.2 to 2.7 nucleotides per minute, 
respectively (Table 4). For cafl-2 and cafl-5, in contrast, the deadenylation rates for 
GAL1-L were more similar to wild-type cells (Table 4; Figure 9B). However, cafl-2 and 
ca fl-5 displayed greater effects on the deadenylation rate for GAL1-S, suggesting that 
they may be defective in deadenylation for a subset of mRNA species. Given that the 
phenotypic analysis of cafl-2 and cafl-5 showed that their caffeine sensitivities were 
halfway between wild-type and the cafl deletion, these in vivo deadenylation data agree 
well with their in vivo phenotypes.
Steady state MFA2vG mRNA analysis in cafl alleles
Deadenylation endpoint analysis of steady state RNA levels of MFA2pG was 
also conducted as cafl has previously been shown to result in endpoints of about 16-20 
A’s as compared to 8-12 A’s for wild-type CAF1 (Tucker et al., 2001). We found that 
cafl-1, -3, and -6 alleles resulted in the longer poly(A) tail length for the pG  fragment 
that results after deadenylation/ decapping/ and 5’-3’ nuclease action on MFA2pG than 
for wild-type CAF1: 24-29 A’s as compared to 11 A’s (Figure 10, lanes 2, 4, 7 compared 
to lane 1; summarized in Table 4). In the cafl-2 and cafl-5 alleles, the deadenylation 
endpoints of the pG  fragment were not significantly affected (lanes 3 and 6). These
41
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Figure 10. cafl-1, -3, and -6 alleles are defective in deadenylation endpoint of 
MFA2pG. Northern analysis of steady state MFA2pG mRNA was conducted with a cafl 
background (EGY188-cl-l) in which LexA-CAFl fusion proteins were expressed as 
indicated. dT refers to removal of oligo(A) by incubation with oligo(dT) followed by 
RNase H digestion. The approximate lengths of the poly(A) tail and migration positions 
of the MFA2pG and pG  fragments are indicated to the left and right, respectively.
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overall results indicate that the severe growth phenotypes of cafl-1, -3, and -6 probably 
result from the inability of the CCR4-NOT complex to properly deadenylate in vivo.
CAF1 affects translation to a greater extent than does CCR4
The cafl deletion has previously been shown to be lethal with a deletion in the 
decapping/translational regulator DHH1 whereas the ccr4 deletion is not lethal with dhhl 
(Maillet and Collart, 2002). In order to determine which CAF1 allele can confer lethality 
with dhhl, we constructed a strain carrying both a dhhl and cafl deletion that was 
covered by a plasmid expressing a GAL1-CAF1 gene. This strain was unable to grow on 
glucose growth conditions when GAL1-CAF1 expression was shut off (not shown). 
Following transformation of LexA-CAFl plasmids encoding each of the above 
mutagenized CAF1 alleles, the LexA-cafl-1, -3, and -6 did not allow growth on glucose 
growth conditions whereas cafl-2, -4, and -5 alleles allowed growth on glucose (data not 
shown). These data suggest the cafl-1, -3, and -6 alleles are also defective in a non- 
deadenylation function. As DHH1 is known to be a decapping regulator (Coller et al., 
2001) and to repress translation (Coller and Parker, 2005), CAF1 could be involved in 
either of both of these functions.
We first tested if CAF1 defects specifically affected the rate of protein synthesis 
under normal non-stress conditions. As indicated in Table 5, a cafl deletion reduced the 
rate of translation to 44% whereas an isogenic ccr4 strain had much less effect on 
translation. These data suggest that CAF1 plays a particular role in translation separate 
from that of CCR4. We next tested if  a cafl allele specifically affected the decapping 
process as compared to ccr4. We analyzed the MFA2pG RNA in this case, as the relative 
abundance of the pG  fragment to that of full-length MFA2pG is an indicator of the
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efficiency of the decapping and 5’-3’ degradation process (Coller et al., 2001; Olivas and 
Parker, 2000). No significant difference in pG  formation relative to that of full length 
MFA2pG was observed between cafl and ccr4, although both reduced the abundance of 
the pG  fragment as compared to the wild-type strain (data not shown). These results 
agree with previous observations concerning cafl and ccr4 effects on pG  fragment 
formation (Tucker et al., 2002 & 2001) and indicate that the reduction in decapping rates 
observed in ccr4 cafl strains is apparently the result of slowed deadenylation in both 
cases.
Identification of DHH1 and STM1 as high-copy suppressors of a yabl-ARRM2 cafl 
synthetic lethality
In an analysis of poly(A) binding protein (PAB1) genetic interactions with CCR4 
and CAF1, we observed that deleting the RRM2 or RRM1 domain of PAB1 was lethal 
with a cafl deletion but not with ccr4 (summarized in Table 5). The RRM2 domain of 
PAB1 is important both for contacting the poly(A) tail and the translation initiation factor 
eIF4G (Deardorff and Sachs, 1997; Kessler and Sachs, 1998; Otero et al., 1999). The 
RRM1 and RRM2 deletions of PAB1 also reduced the in vivo rate of protein synthesis by 
29 and 15%, respectively, whereas other RRM deletions and of the C-terminal region of 
PAB1 had less than 4% effects on the rate of protein translation (data not shown) and 
were not lethal with cafl. Subsequent genetic analysis showed that the cafl-1 , -3, and -6 
alleles but not those of cafl-2 or cafl-5 were similarly lethal with PAB1-ARRM2 (data 
not shown). These genetic interactions support the above observations that CAF1 is 
involved in a translation process.
Since overexpression of CCR4 is known to partially reduce the deadenylation
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Table 5. Summary of genetic interactions of cafl and ccr4 with translation factors.
Rate of protein synthesis Lethality with
CDC33 cdc33-l dhhl PAB1-ARRM1 PAB1-ARRM2
wt 100% 36% no no no
cafl 44% 13% yes yes yes
ccr4 67% 24% no no no
Rates of protein synthesis represent the average of three to four determinants. SEM 
values were less than 3%. All strains were isogenic to AS319. PAB1-ARRM1 and PAB1-
ARRM2 refer to AS319/YC505 and AS319/YC506, respectively.
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Figure 11. YEpl3 LEU2 high-copy yeast library screening. (A) Overexpression of 
DHH1 and STM1 suppress the synthetic lethality of the cafl PAB1-ARRM2 double 
mutant. Strains ASY319-cl-lN/YC506 (cafl paW/pYC360 (PAB1 URA3) pYC506 
(PAB1-ARRM2 TRP1)) was transformed with the YEpl3-LEU2 plasmids carrying MPTO 
(CAF1), MPT1 (DHH1), MPT2 (CCR4), MPT3 (PKC1), MPT4 (STM1), MPT5 (PUF5) 
(18) and PAB1. Transformants were selected on minimal media lacking uracil, tryptophan, 
and leucine and replica plated on FOA media to lose the pYC360 plasmid. The plate was 
incubated at 30°C for 7 days before scanning. (B) Overexpression of CAF1 can suppress 
caffeine sensitivity associated with cdc33-l. Strain 1881/YC360 (PAB1 URA3) was 
transformed with MPTO, MPT2, or YEpl3.
46
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
defect in a cafl background (Tucker et al., 2002), one simple interpretation of the cafl 
PAB1-ARRM2 lethality was that a lack of deadenylation was lethal with PAB1-ARRM2. 
However, as ccr4 was not lethal with PAB1-ARRM2, this simple model is probably not 
correct. To clarify the genetic interaction between cafl and PAB1-ARRM2, we conducted 
a genetic screen to identify genes whose overexpression could rescue this synthetic 
lethality. Ahigh-copy YEpl3-LEU2 yeast genomic library was subsequently transformed 
into a strain carrying the cafl PAB1-ARRM2 allele. Eleven plasmids that suppressed the 
cafl PAB1-ARRM2 lethality were identified. Five of these plasmids contained CAF1 and 
one plasmid carried PAB1. All of these plasmids suppressed the lethality strongly (Figure 
11). Of the remaining five plasmids, two displayed moderate suppression, and of these 
one was found to carry the DHH1 gene and the other the STM1 gene. The remaining 
three weakly suppressing plasmids were containing OKP1, RNR1, and POL4.
Because previous analysis has identified several multi-copy suppressors o f a 
cafl deletion, including that of DHH1, CCR4, PKC1, STM1, and PUF5 (Hata et al., 
1998), we tested whether overexpression of each of these different genes in a strain 
carrying cafl PAB1-ARRM2 and PAB1-URA3 could suppress the cafl PAB1-ARRM2 
lethality and allow loss of PAB1-URA3 and subsequent growth on 5’-FOA media. As 
shown in Figure 11 A, we failed to observe any high-copy suppression of cafl PAB1- 
ARRM2 by CCR4, PKC1, or PUF5. This observation provides additional genetic 
evidence supporting the functional participation of CAF1 in a process that is separate 
from the role involving CCR4.
One model to explain the role of DHH1 in suppressing the cafl PAB1-ARRM2 
lethality would be that overexpression of DHH1 could compensate for the deadenylation 
defect caused by cafl mutants. As shown in Figure 12 in analyzing the steady state
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Figure 12. Overexpression of DHH1 cannot suppress the deadenylation defects of 
cafl mutant alleles. Northern blot analyses of steady state MFA2pG mRNA were 
conducted for analyzing MFA2pG poly(A) tail distribution in each of the cafl mutant 
alleles with or without overexpression of DHHl. Flag-DHHl was overexpressed on 
plasmid pRP1053. Flag-DHHl or vector control were transformed into EGY188-cl-l 
containing the different LexA- cafl mutants and pRP485 (MFA2pG). Steady state mRNA 
samples were subjected to electrophoresis on 6%/7.5M urea polyacrylamide gels.
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MFA2pG levels, overexpression of DHH1, however, had no effect on the deadenylation 
defects observed with the cafl-1 and -6 alleles. In both cafl-1 and cafl-6 at steady state 
MFA2pG mRNA does not deadenylate completely and has longer poly(A) tail lengths 
than the wild-type regardless of whether DHH1 was overexpressed or not. These data 
confirm that DHH1 functionally interacts with CAF1 through a mechanism that does not 
directly pertain to deadenylation. As DHH1 is involved in translation processes (Coller et 
al., 2001; Coller and Parker, 2005) and STM1 can interact with the ribosome and eIF4E 
(Gavin et al., 2002), we determined whether overexpression of CAF1 or CCR4 could 
complement a defect in translation factor eIF4E (cdc33-l allele). As shown in Figure 
11B, overexpression of CAF1 but not that of CCR4 could complement the caffeine 
sensitivity displayed in a strain carrying the cdc33-l allele. As cdc33-l is specifically 
defective in binding the 5’ mRNA cap (Altman and Trachsel, 1989), these results provide 
further support for a functional role for CAF1 in translation distinct from its role in 
deadenylation.
A translation defect in PAB1 specifically reduces deadenylation when coupled with a 
cafl deletion.
The above results implicate CAF1 in affecting translational process. As the 
primary lesion of a CAF1 deletion is decreased deadenylation, it might be that CAF1 
serves to communicate a positive effect between deadenylation and translation. However, 
previously it has been shown that defects in translation initiation factors accelerated 
deadenylation (Schwartz and Parker, 1999), implying that they play a negative role in 
deadenylation. In order to determine if other aspects of translation played required roles 
for deadenylation, we examined the effects of two defined PAB1 defects in translation on
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deadenylation: PAB1-134 and PAB1-184. PAB1-134 has been shown to reduce 5’cap- 
dependent translation in vitro whereas PAB1-184 affected poly(A)-dependent translation, 
apparently through reduced binding to eIF4G (Otero and Sach, 1999).
Using the analysis of the steady state levels of GAL1 mRNA as an initial 
determination of the effects of these PAB1 variants on deadenylation, we found that 
neither PAB1-134 nor PAB1-184 affected the distribution of steady state poly(A) tail 
lengths as compared to wild-type PAB1 (Figure 13A). In contrast, ccr4 or cafl deletions 
displayed much longer poly(A) tail lengths (Figure 13A), indicative of slowed 
deadenylation (Tucker et al., 2001). Subsequent analysis of PAB1-134 and PAB1-184 
effects on the deadenylation rate of the MFA2pG mRNA using pulse chase analysis 
indicated that neither affected the deadenylation process (data not shown). However, 
when PAB1-134 was combined with the cafl deletion, the steady state analysis of GAL1- 
L or GAL1-S showed that the poly(A) tail lengths were much longer that with cafl alone, 
as if there were a complete block in deadenylation (Figure 13A; data not shown). In 
contrast, PAB1-134 had no effect on the poly(A) tail length when combined with a ccr4 
deletion (Figure 13A). PAB 1-184, as comparison, did not show this effect with cafl 
(Figure 12A). Analysis of the actual deadenylation rate for GAL1-L showed that a cafl 
PAB 1-134 background caused a severe slowing of the rate of deadenylation (0.7 A’s/min 
compared to 3.7 A’s/min for wild type PAB1 and 2.2 A’s/min for cafl) (Figure 13B). 
These observations indicate that some defects in translation can cause corresponding 
defects in deadenylation and that proper translation coupled with CAF1 is required for 
complete deadenylation by CCR4 (see Discussion).
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Figure 13. PAB1-134 blocks deadenylation in a cafl background. A. Steady state 
mRNA analysis of GAL1 was conducted as described in Figure 6 . wt-AS319; ccr4- 
AS319-la-uN; co/7-AS319-cl-lN. B. Pulse-chase analysis of GALJ-L mRNA 
deadenylation was conducted as described in Figure 4. PAB1-134 refers to 
AS319/YC545 and PAB1-184 refers to AS319/YC538. YC545 expresses the PAB1 
protein with residues 134HPD137 replaced with DKS and YC538 has residues 
184DAL187 of PAB1 replaced with EKM (29).
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Discussion
It has been shown that the CAF1 C-terminal domain purified from E. coli 
exhibits an exonuclease activity with a poly(A) preference (Daugeron et al., 2001; Thore 
et al., 2003). Our previous mutation studies of CAF1 established, however, that its 
RNase function is not required for the in vivo deadenylation process (Viswanathan et al., 
2004). This discrepancy prompted us to identify the functional domains that are critical 
for CAF1 to perform its role in mRNA turnover. By targeting only those sequences 
absolutely conserved amongst all CAF1 ortho logs but not present in other members of 
the DEDDh family of nucleases, we sought to identify CAF1-specific functions. This 
methodology led us to define several separable functional regions in the CAF1 protein.
HA immunoprecipitation (data not shown) and FLAG pull-down analyses with 
CAF1 mutants used in this study showed that three amino acids (213FRS215) deleted in 
ca fl-2 are required for the CAF1 interaction with CCR4. As mammalian CAF1 can also 
bind yeast CCR4, it would be expected that the CAF1 residues involved in this contact 
have been retained evolutionarily. Residues 213-215 are found in a loop structure whose 
structure was not apparently fixed enough to be determined in the X-ray analysis of 
CAF1 (Thore et al., 2003). The cafl-2 protein displayed only a weak caffeine sensitive 
phenotype and intermediate effects on deadenylation in vivo as compared to a cafl 
deletion or to mutations in other regions of the CAF1 protein that were still capable of 
binding CCR4. It appears, therefore, that CAF1 binding to CCR4 is not the central 
function of CAF1 for deadenylation. This conclusion is in agreement with results from 
our previous analysis wherein mutations in CCR4 that significantly reduced CCR4 
binding to CAF1 appeared phenotypically wild-type (Clark et al., 2004).
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In contrast to cafl -2, the most important regions for CAF1 function in vivo were 
identified by the cafl-1 , -3, and -6 alleles. These three cafl mutant alleles displayed 
severe defects in poly(A) shortening like that of a cafl deletion and were as caffeine 
sensitive as the cafl deletion. Three observations suggest that cafl-1 and cafl-3  alleles 
are equivalent physically and functionally. First, the X-ray crystal structure showed that 
cafl-1 and cafl-3 alleles are located in the same region where two p sheets (p i and p4) 
are aligned side by side (Figure 2A). Second, yeast cells carrying either of the two alleles 
displayed a dominant negative growth phenotype. Third, both alleles showed similar 
GAL1 deadenylation rates and defects in MFA2pG endpoints. These observations indicate 
that the cafl-1 and cafl-3 alleles define a novel functional region of yeast CAF1 required 
for its cellular function. The cafl-6 allele, deleting residues 340DFE342, define a third 
functional region of CAF1. Phenotypes associated with cafl-6 are nearly identical to 
those observed for cafl-1 and -3, although the location of the cafl-6 mutation is on the 
opposite site of the CAF1 protein as that of cafl-1 and -3. Whether the putative contacts 
made by the cafl-6 region (a 8 helix) are to the same factors as presumed to contact the 
p 1 and p4 sheets remain to be determined. At least, both regions and these putative 
contacts are central to CAF1 in vivo function.
In that we also observed that none of our CAF1 alleles severely affected in vitro 
CCR4 deadenylation activity regardless of whether the alleles blocked CCR4 binding to 
CAF1 (cafl-2) or not, we conclude that CAF1 does not directly regulate CCR4 activity 
in vitro. This is in agreement with our previous observations (Chen et al., 2002; Clark et 
al., 2004). All of the CAF1 alleles interacted equivalently well with NOT1, further 
suggesting that the identified roles for CAF1 in vivo are not defined through this 
interaction either.
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What, then, is the role for CAF1 in vivo? Several previous observations and 
those made herein suggest that CAF1 affects non-deadenylation processes in addition to 
its effects on deadenylation. These non-deadenylation effects could be on decapping or 
translation. However, we and others (Tucker et al., 2002 & 2003) have observed that a 
cafl deletion does not specifically affect decapping in vivo as compared to the effects 
displayed by ccr4. A role, instead, for CAF1 in translation separate from CCR4 is 
supported by a number of observations. First, a cafl deletion displays synthetic lethalities 
with defects in translational regulators that ccr4 deletion does not. A cafl deletion, but 
not that of ccr4 is lethal with dhhl, a decapping regulator that is required for translational 
repression (Maillet and Collart, 2002; Coller and Parker, 2005; data not shown). The 
cafl-1, -3, and -6 alleles also displayed this lethality with dhhl. In addition, cafl and the 
cafl-1, -3, and -6 alleles were also lethal with PAB1-ARRM1 and PAB1-ARRM2, a 
phenotype not observed with ccr4. Only these two deletions in PAB1 affected translation. 
Second, we found that cafl PAB1-ARRM2 lethality can be suppressed by overexpression 
of two factors linked to translation, DHH1 and STMl. As overexpression of CCR4 
cannot suppress this lethality, although it can suppress cafl deadenylation defects 
(Tucker et al., 2002), it is clear that deadenylation defects alone are not contributing to 
cafl PAB1-ARRM2 lethality. In vivo immunological and biochemical studies with STMl 
have shown that it is localized in the cytoplasm and associated with primarily 80S 
monosomes and polysomes (Van Dyke et al., 2004). Two-hybrid data further suggest 
physical interaction of STMl with the translation initiation factor eIF4E (Gavin et al., 
2002). Third, we showed that a cafl deletion exerts more severe effects on translation 
that does ccr4. Fourth, we showed that overexpression of CAF1 but not CCR4 can 
suppress the caffeine sensitivity associated with a cap binding defect in eIF4E.
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As CAF1 is required for the deadenylation process, the above observations 
supporting a role for CAF1 in translation separate from its contact to CCR4, suggest that 
there may be a required interplay between translation and deadenylation. Previously, 
defects in translation initiation factors were found to enhance deadenylation, not slow it 
(Schwartz and Parker, 1999). We have found, however, that the defect in PAB 1-134 that 
reduces cap-dependent translation in vitro, is required for deadenylation in a cafl 
background. This result implies that CAF1 and the translation function defined by PAB1- 
134 are both required for the full CCR4 deadenylation process. PAB 1-134 did not affect 
deadenylation in a ccr4 background suggesting that its effects are not through PAN2. 
Therefore, instead of translation strictly inhibiting deadenylation, these results suggest an 
additional positive role for translation in deadenylation. CAF1 may be the mediator of 
this role, as it has a number of genetic and functional interactions with translation factors 
and is required for deadenylation. CAF1 may, for instance, monitor the translation status 
and, in turn, communicate that to the CCR4-NOT complex. The exact role for CAF1 in 
these two processes may require the development of in vitro systems that are both 
translationally competent and whose mRNA deadenylation is CCR4-NOT dependent.
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CHAPTER II
EFFECT OF PUF3 AND TRANSLATION INITIALTION FACTORS ON mRNA
DEADENYLATION
Introduction
Post-transcriptional control in eukaryotic cells is essential for proper regulation 
of gene expression. The post-transcriptional processes that regulate the turnover o f an 
mRNA and the control of its translation in the cytoplasm are the major sites at which 
such coordinated gene expression control occurs. Such control is commonly mediated by 
mRNA binding proteins, many of which are specifically targeted to a specific gene 
sequence in 3’ untranslated region (3’-UTR) (Derrigo et al., 2000; Grzybowska et al., 
2001; Mazumder et al., 2003).
The first two members of the RNA-binding protein family were Drosophila 
melanogaster Pumilio and Caenorhabditis elegans FBF; hence, the group is now referred 
to as PUF (Zamore et al., 1997) or Pum-HD (Zhang et al., 1997) proteins. Pumilio from 
Drosophila melanogaster promotes anterior/posterior patterning of the early embryo by 
binding the 3’-UTR of hunchback mRNA and subsequently repressing its translation 
(Murata and Wharton, 1995) and stimulating its deadenylation (Wreden et al., 1997). C. 
elegans FBF regulates the germline swich from spermatogenesis to oogenesis by 
repressing fem-3 (Zhang et al., 1997). PUF proteins in yeast regulate aging, 
mitochondrial function and mating-type switching (Kennedy et al., 1997; Olivas and
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Parker, 2000; Tadauchi et al., 2001) whereas Dictyostelium PufA promotes vegetative 
growth (Souza et al., 1999).
The yeast Saccharomyces cerevisiae contains six members of PUF protein 
family (PUF1 through 6), which are containing 6-8 pumilio repeats (Zamore et al., 1997). 
Yeast and higher eukaryotic PUFs have been shown to bind 3’-UTR sequences and to 
either stimulate the degradation of target mRNA or repress translation process (Olivas 
and Parker, 2000; Jackson et al., 2004; Chagnovich and Lehnmann, 2001; Wreden et al., 
1997; Wharton et al., 1998; Gu et al., 2004). To date, only three of the yeast PUFs have 
identified the roles in controlling specific RNA targets. PUF3 binds the 3’-UTR of 
COX17 mRNA and promotes its deadenylation and subsequent decay (Olivas and Parker, 
2000), PUF5 binds to the 3’-UTR of the HO mRNA, repressing its expression and 
stimulating its decay (Tadauchi et al, 2001), and PUF6 binds the 3’-UTR of the ASH1 
mRNA to regulate its translation and localization (Gu et al., 2004). In addition to these 
target mRNAs, microarray analysis utilizing affinity tagging of five PUF family of 
protein has identified several hundred candidate mRNA targets and the mRNAs targeted 
by each PUF. These mRNA encode functionally related families of proteins indicating 
that combinatorial binding of mRNAs by specific RNA binding proteins is a critical tool 
for efficient reprogramming of gene expression (Gerber et al., 2004; Keene, 2003;
Murata et al., 1995). For example, PUF3 was specifically bound to mRNAs encoding 
mitochondrial proteins, PUF1 and PUF2 were associated with mRNA encoding 
membrane-associated proteins and PUF4 and PUF5 were selectively interacted with 
mRNAs encoding nuclear components (Gerber et al., 2004).
PUF proteins contain 6-8 pumilio repeats (Zamore et al., 1997) through which 
3’-UTR of target mRNA binds. The binding sequences of all RNA targets analyzed to
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date consists of at least a UGUR sequence and 4-6 additional flanking sequences 
(Wickens et al., 2002; White et al., 2001; Zamore et al., 1997). The formation of PUF 
protein complexes on 3’-UTRs also requires additional sequences, due to other RNA- 
binding proteins that are working partners of PUF proteins (Sonoda et al., 1999).
Materials and Methods
Yeast strains and growth conditions
The genotypes of the S. cerevisiae strains used are listed in Table 5. Yeast strains 
were grown on synthetic medium supplemented with 2% raffinose. In order to conduct 
transcriptional pulse-chase analysis, GAL1 promoter was induced by 2% galatose and 
repressed by 4% glucose.
In vivo transcriptional pulse-chase analyses
Transcriptional pulse-chase experiments of COX17 RNA were performed 
essentially as described (Decker and Parker, 1993; Muhlrad and Parker, 1992) on strains
RP840 (wild-type), RP840-la (ccr4A), RP1241 (puf3/S), RP1241-la (ccr4puf3) and PP2
(puf3 pan2). These strains contain the plasmid pRP1007, in which the COX17 gene is 
under the control the GAL1 promoter. Transcription was induced for 10-20 min by the 
addition of galatose and then rapidly repressed by adding glucose. Poly (A) tail lengths 
were monitored by the cleavage of COX17 mRNA just upstream of the stop codon using 
RNAseH reactions with the probe COX17/6n (5’-GCCATAACCCTTCATGCACTC-3’) 
as described (Olivas and Parker, 2000). Digested and purified total RNA was separated
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on 6 % denaturing polyacrylamide gels at 250V for 4.5 hours and transferred to nylon 
membrane for probing with radiolabeled COX17/3’-end (5’- 
GGTTGTCGGCAGACTGTCAC-3 ’) (Olivas and Parker, 2000).
For the snapshot analysis of COX17 mRNA, yeast strains were grown to mid-log 
phase (ODeoo of 0.7), transferred to fresh media. Cells were harvested at 20 minutes after 
induction and 5 minutes after repression.
Transcriptional pulse-chase experiments of GAL1 gene were conducted as 
described in Chapter 1 except for the growth condition. Briefly, the temperature sensitive 
cells were grown to mid-log phase in medium containing 2% raffinose at permissive
temperature (25 °C), harvested, and resuspended in a fresh media prewarmed to a non-
permissive temperature (38°C). After 20 min in a shaking incubator, galactose (2% final
conc.) was added to induce transcription and finally glucose (4% final conc.) was added 
to shut off transcription.
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Table 6. Yeast strains
Strain Genotype
RP840 MATa his4-539 leu2-3 112 trpl-1 ura3-52 cupl::LEU2/PGKlpG/MFA2pG
RP840-la Isogenic to RP840 except ccr4::URA3
RP1320 MATa his3h i  leu2-3, 112 lys2-201 trpl ura3-52 
cupl: :LEU2/PGKlpG/MFA2pG tif4631: :LEU2
RP1320-la Isogenic to RP1320 except ccr4::URA3
RP1326 MATa leu2 prtl-63 trpl ura3 cupl::LEU2/PGKlpG/MFA2pG
RP1326-la Isogenic to RP1326 except ccr4:: URA 3
RP1241 MATa his4-539 leu2-3 112 trpl-1 um3-52 cupl::LEU2/PGKlpG/MFA2pG 
puf3::Neo
RP1241-la Isogenic to RP1241 except ccr4::URA3
PP2
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Results and Discussion
PUF3 affects both CCR4 and PAN2 in COXl7 mRNA deadenylation
It has been reported that PUF3 specifically promotes degradation of CO Xl7 
transcript by enhancing deadenylation and subsequent turnover through binding the 3’ 
UTR of COX17 mRNA (Olivas and Parker, 2000). Since the CCR4-NOT complex was 
revealed to be the major deadenylase complex in yeast, our lab tested if physical contact 
exists between PUF3 and CCR4-NOTs. Using GST-PUF3 and FLAG-PUF3, we have 
established that PUF3 protein physically contact CCR4-NOT complex in vitro and in 
vivo (Yeuh-chin Chiang, personal communication) suggesting that PUF3 acts through the 
CCR4-NOT complex to accelerate degradation.
To test the effect of PUF3 on CCR4 activity in vivo, we constructed ccr4 and
pan2 deletion strains in combination withpuf3L. In this way, we would be able to
determine if  PUF3 affected CCR4 and/or PAN2 deadenylation of COX17. We first 
analyzed the poly(A) distributions and deadenylation status of COXl 7 in a short time 
period by performing Northern blot analysis. In this experiment, yeast cells were 
harvested after 20 minute activation and 5 minute repression of COX 17 mRNA 
transcription (See Materials and Methods). Total RNA from those strains were isolated 
and subjected in a Northern blot analysis after RNase H digestion (See Materials and 
Methods). As described previously (Olivas and Parker, 2000), COXl 7 mRNA poly(A) 
tail distribution in wild-type is weighted toward longer tails of 40-60 A residues as 
compared to 20-45 A residues inpuf2 deletion strains (Figure 14). This observation 
indicates that PUF3 is necessary to modulate the poly(A) tail status of COXl 7 mRNA.
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For the degradation pattern of COXl 7 mRNA within 5 minutes, all mutant strains 
showed slower degradation except wild-type. Notably, puf3 ccr4 double mutants seemed 
to have severe defect in deadenylation process.
To determine the deadenylation rates of COXl 7 mRNA in these mutant strains, 
we conducted transcriptional pulse-chase experiments. In this experiment, COXl 7 
mRNA is transcribed from a plasmid under the control of GAL1 promoter. As described 
previously (Jackson et al., 2004), the poly(A) tails of COXl 7 mRNA from wild-type 
strain were deadenylated completely within 2-4 minutes, and all transcripts disappeared
within 10 minutes. In contrast, deadenylation rates of COXl 7 in pufSA  strain, as
previously demonstrated (Olivas and Parker, 2000) slowed considerably as compared to
that of wild-type. The average rates of deadenylation of COXl 7 in wild-type and puf3A
were 5.0 and 1.3 A’s/minute respectively. The ccr4 deletion stain also displayed a slower 
rate of deadenylation such that COXl 7 transcripts did not become fully deadenylated
until 20 min. Both of the deadenylation rates of ccr4A and puf3A strains were 1.3—1.4
A’s/min suggesting that these proteins are equally important for the COXl 7 
deadenylation process. We next tested if PUF3 protein also affects COXl 7 deadenylation
by PAN2, a deadenylase involving in the initial poly(A) tail trimming, by using ccriA
puf3A  double deletion stain. As we predicted in snapshot analysis (Figure 15),
deadenylation of COXl 7 mRNA was completely blocked suggesting that PUF3 also 
affects PAN2 for COXl 7 deadenylation. On the other hand, the puf3 pan2 double
deletion strain displayed slower deadenylation as compared to the puf3A strains. It is
interesting to note that puf3 pan2 strain may lost poly(A) tail length control because even
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Figure 14. Snapshot of poly(A) tail distribution of COXl 7 mRNA. Transcription of 
COXl 7 mRNA was induced for 20 min by adding galactose in growing media (I) and 
repressed for 5 min by the addition of glucose (R). Total RNA from wild-type (WT) or 
indicated deletion strains was cleaved utilizing RNase H reactions to produce 3’-UTR- 
poly(A) tail fragments and analyzed in Northern blots (see Materials and Methods). dT 
refers to deadenylated COXl 7 RNA by oligo dT and subsequent RNase H digestion.
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Figure 15. PUF3 affects COXl 7 deadenylation both by CCR4 and PAN2. (A) Shown 
are the Northern blots of COXl 7 transcriptional pulse-chase analyses from wild-type and
indicated mutant strains; ccr4t\, puf3A, ccr4A pu/3A, andpuf3A pan2A. The numbers
on the blots are minutes following transcriptional repression. dT lane in each blot 
corresponds to RNA from the 0 min time point in which the poly(A) tail was removed by 
oligo dT and RNase H. (B) The numbers above the blot denotes minutes after
transcriptional activation from puf3A pan2A strain background.
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one minute induction of COXl 7 transcription failed to get a proper pulse of COXl 7 
mRNA containing 45-60 poly(A) tails (Figure 15B). This phenomenon may due to the 
involvement of PUF3 in poly(A) tail length control by affecting PAN2 function. Further 
analysis will be needed to verify this hypothesis.
Defects in translation initiation factors affect PAN2 deadenylation
Translation initiation defects such as in prtl-63  or deletion of eIF4G accelerate 
deadenylation (Schwartz and Parker, 1999), but it has not been known if those defects 
affect both CCR4 and PAN2. If translation initiation factors (TIFs) are affecting some 
general feature of mRNP structure, then defects in TIFs would also be expected to affect 
PAN2 function. To test this hypothesis, we used yeast strains harboring defect in TIFs 
such as eIF3 (PRT1) and eIF4Gl (TIF4631) in combination with ccr4 deletion. We first
tested if defects in PRT1 {prtl-63) and TIF4631 (eIF4GA) accelerated deadenylation as
described previously (Schwartz and Parker, 1999). As shown in Figure 16, for the wild- 
type strain it took about 5 min for GAL1-L poly(A) tails to be shortened to the oligo(A) 
form. Whereas in the tif4631 and prtl-63  backgrounds, to oligo(A) form appears in about 
2 min. Calculation of the rate of deadenylation indicates that deadenylation for tif4631 
occurred at about 9.7 A’s/min and for prtl-63  at about 12.5 A’s/min which are about 1.5 
and 2 fold as fast compared to wild-type (6.3 A’s/min) (Figure 16; Table 7). These results 
agree well with previous decay analyses with MFA2 and PGK1 mRNAs in tif4631 and 
prtl-63  bacgrounds (Schwartz and Parker, 1999). Faster deadenylation by PAN2 was 
also observed in tif4631 and prtl-63 with a ccr4 deletion, when only PAN2 was active,
as compared to ccr4h. Changes in the deadenylation rate were increased about 1.6 to
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Figure 16. Lesions in translation initiation factors affect deadenylation both by 
CCR4 and PAN2. (A) Nothem blots of transcriptional pulse-chase experiments 
examining the deadenylation of GAL1-L mRNA in translation initiation mutants are 
shown. Minutes following transcription repression are given above each blot. The 
numbers after the A’s in the cartoons represent the range of poly(A) tail sizes. dT lanes 
denotes GAL1-L mRNA whose poly(A) tail have been completely removed by cleavage 
with RNase H and GAL1 probe 3 oligo nucleotide (see the Materials and Methods in 
Chapter I). (B) Graphical representation of GAL1-L deadenylation in mutant strains 
shown in A.
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Table 7. Effects of translation initiation factors on deadenylation of GAL1-L mRNA
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1.7-fold as compared to the ccr4 control strain (Figure 16; Table 7).
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